Medir
South Korea · $6.7M raised
- Business Model
- B2C
- Website
- medb.kr
- Total Funding
- $6.7M
- Last Round
- $6.7M SeedApr 2022
- Rounds
- 1
About
Operator of online medical care and prescription drug delivery platform intended to serve medical consumers, hospitals, and pharmacies. The company's platform offers a structure in which a delivery person delivers prescription drugs to users at a pharmacy close to the hospital where they received treatment and a hyperlocal policy that only exposes nearby hospitals based on their location, enabling patients to get treatment safely and quickly from the specialists in their neighborhood.
Summary
Medir is a Healthcare company based in South Korea. It has raised $6.7M in total across 1 round, most recently a $6.7M Seed round in Apr 2022. Investors include 500 Global.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2022
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe